Feasibility and Safety of Rapid Drug Desensitization for Chemotherapy-Induced Maculopapular Eruptions
Journal of Clinical Medicine · 15.08.2026 · 15 (16) · 6320
DOI: 10.3390/jcm15166320 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 15.08.2026. Verfasst von Meryem Demir und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Occupational & Environmental Respiratory Diseases and Asthma, Division of Immunology and Allergy, Department of Pulmonary Medicine, Fac…. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background/Objectives: Chemotherapy drug (ChD)-induced maculopapular eruptions (MPEs) may interrupt optimal cancer treatment when no equally effective alternative therapy is available. Evidence supporting rapid drug desensitization (RDD) for delayed-type MPE remains scarce. We aimed to evaluate the feasibility and safety of RDD in patients with ChD-induced MPE.
Methods
Adult patients with ChD-induced MPE who underwent RDD between January 2021 and January 2024 were evaluated. Delayed MPE recurrence was assessed until the subsequent chemotherapy cycle.
Results
A total of 63 RDD procedures were performed in 10 patients with ChD-induced MPE, most commonly triggered by taxanes and platinum agents. The median onset of the index reaction was 60.0 h (24.0–336.0), and delayed intradermal tests were positive in 2 of 9 tested patients (22.2%). No delayed MPE recurrences were observed during the predefined follow-up period until the subsequent chemotherapy cycle. Immediate breakthrough reactions occurred in 3 of 10 patients (30.0%), corresponding to 17 of 63 RDD procedures (27.0%), and were limited to mild flushing and pruritus that resolved with antihistamines with or without low-dose corticosteroids. All RDD procedures were successfully completed without severe systemic reactions, and all patients were discharged on the same day.
Conclusions
In carefully selected patients with delayed-type MPE, RDD appears to be a feasible and safe short-term strategy for enabling continuation of essential chemotherapy within the predefined observation period. As this pilot study includes a small and heterogeneous patient population with limited follow-up, the findings should be considered preliminary and hypothesis-generating and warrant confirmation in larger prospective studies with longer follow-up.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Occupational & Environmental Respiratory Diseases and Asthma, Division of Immunology and Allergy, Department of Pulmonary Medicine, Faculty of Medicine, Ege University, 35100 Izmir, Türkiye.
- Department of Dermatology, Faculty of Medicine, Ege University, 35100 Izmir, Türkiye.
- Translational Pulmonary Research Center-EgeSAM, Ege University, 35100 Izmir, Türkiye.
- Department of Medical Oncology, Faculty of Medicine, Ege University, 35100 Izmir, Türkiye.
ORCID-Profile: Meryem Demir, Sercan On, Su Ozgur, Erdem Goker
Zitieren
APA
Demir, M., Duman, N., Karakus, H. S., On, S., Okan, K., Akten, H. S., Inan, S., Ozgur, S., Goksel, T., Goker, E., & Goksel, O. (2026). Feasibility and Safety of Rapid Drug Desensitization for Chemotherapy-Induced Maculopapular Eruptions. Journal of Clinical Medicine, 15(16), 6320. https://doi.org/10.3390/jcm15166320
Vancouver
Demir M, Duman N, Karakus HS, On S, Okan K, Akten HS, et al. Feasibility and Safety of Rapid Drug Desensitization for Chemotherapy-Induced Maculopapular Eruptions. Journal of Clinical Medicine. 2026;15(16):6320. doi:10.3390/jcm15166320
BibTeX
@article{Demir2026,
author = {Demir, Meryem and Duman, Nilay and Karakus, Haydar Soydaner and On, Sercan and Okan, Kasim and Akten, Hatice Serpil and Inan, Sinem and Ozgur, Su and Goksel, Tuncay and Goker, Erdem and Goksel, Ozlem},
title = {Feasibility and Safety of Rapid Drug Desensitization for Chemotherapy-Induced Maculopapular Eruptions},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {16},
pages = {6320},
doi = {10.3390/jcm15166320}
}
EUVIMED